| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.19B | -59.3% |
| R&D Expense | $2.33B | +80.1% |
| SG&A Expense | $1.60B | +76.0% |
| Operating Income | -$2.71B | -188.1% |
| Interest Expense | $88.9M | +204.9% |
| Pre-tax Income | -$3.06B | -201.2% |
| Income Tax | -$439.6M | +26.4% |
| Net Income | -$2.62B | -172.4% |
| EPS (Basic) | -$11.81 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.43B | -37.9% |
| Current Assets | $86.45B | +370.5% |
| Total Assets | $89.72B | +321.7% |
| Current Liabilities | $80.82B | +607.7% |
| Long-term Debt | $3.39B | +0.3% |
| Total Liabilities | $84.27B | +465.8% |
| Stockholders' Equity | $5.45B | -14.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.59B | -114.8% |
| Capital Expenditures | $2.9M | +0.8% |
| Investing Cash Flow | -$663.8M | +41.0% |
| Financing Cash Flow | -$5.84B | -277.8% |
| Free Cash Flow | -$1.59B | -114.8% |
| -167.6% |
| EPS (Diluted) | -$11.83 | -181.6% |